Naltrexone And Bupropion
Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Acute Treatment
Orexigen Therapeutics, Inc · Phase 2/3 · Completed · Enrollment 136
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| BWL + NB medication | Obesity or overweight | n/r | 16 | n/r | n/r |
| BWL + Placebo | Obesity or overweight | n/r | 16 | n/r | n/r |
| NB medication | Obesity or overweight | n/r | 16 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 16 | n/r | n/r |